|
|
Core C - Resource Core |
| 5P50AR052646-17 |
|
NIAMS |
2022 |
|
|
Core B - Training Core |
| 5P50AR052646-17 |
|
NIAMS |
2022 |
|
|
Core A - Admin Core |
| 5P50AR052646-17 |
|
NIAMS |
2022 |
|
|
Viral Vector Core |
| 5P50AR065139-09 |
|
NIAMS |
2022 |
|
|
Facioscapulohumeral Dystrophy Clinical Trial Foundations |
| 5P50AR065139-09 |
|
NIAMS |
2022 |
|
|
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV |
| 5P50AR065139-09 |
|
NIAMS |
2022 |
|
|
Administrative Core |
| 5P50AR065139-09 |
|
NIAMS |
2022 |
|
|
IMPACCT: Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials |
| 5U01AR079113-02 |
|
NIAMS |
2022 |
|
|
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing |
| 5UH3AR075336-05 |
|
NIAMS |
2022 |
|
|
Core A - Admin Core |
| 2 P50 AR052646-16A1 |
SWEENEY, H LEE |
NIAMS |
2021 |